Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GH Research PLC - Ordinary Shares (NQ:GHRS)

20.35 +0.23 (+1.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 259,863
Open 20.44
Bid (Size) 19.80 (100)
Ask (Size) 22.70 (100)
Prev. Close 20.12
Today's Range 19.75 - 21.60
52wk Range 11.32 - 25.94
Shares Outstanding 52,020,849
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
GH Research Announces Publication of Phase 2a Postpartum Depression Results
From GH Research PLC
Via GlobeNewswire
News headline image
These Analysts Revise Their Forecasts On GH Research After Q1 Results ↗
GH Research (NASDAQ:GHRS) reported a larger loss than expected in Q1. Analysts lowered price targets, stock fell 3.4%. CEO noted progress in GH001 program. 
Via Benzinga

Performance

YTD
+53.7%
+53.7%
1 Month
-4.3%
-4.3%
3 Month
+27.3%
+27.3%
6 Month
+39.1%
+39.1%
1 Year
+48.5%
+48.5%

More News

Read More
News headline image
GH Research Reports First Quarter 2026 Financial Results and Provides Business Update
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Announces Pricing of $117.5 Million Underwritten Offering
From GH Research PLC
Via GlobeNewswire
These stocks are gapping in today's session ↗
Via Chartmill
News headline image
GH Research Welcomes White House Executive Order to Accelerate Medical Treatments for Serious Mental Illness
From GH Research PLC
Via GlobeNewswire
News headline image
The 15-Minute Breakthrough: A Deep Dive into GH Research (GHRS) and the Future of Rapid-Acting Psychedelics
Via Finterra
Topics Cannabis Initial Public Offering Intellectual Property
News headline image
GH Research Announces Publication of Phase 2b Results for Mebufotenin (GH001) in JAMA Psychiatry and Reports New Finding of Severity-Independent Efficacy in TRD
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Full Year 2025 Financial Results and Provides Business Update
From GH Research PLC
Via GlobeNewswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
Why Is GHRS Stock Rising Today? ↗
Via Stocktwits
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment ↗
Via Stocktwits
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
GH Research to Announce IND Status for GH001
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research PLC (NASDAQ:GHRS) Reports Q3 2025 Earnings Beat and Clinical Progress ↗
Via Chartmill
Topics Earnings
News headline image
GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
News headline image
Depression-Focused GH Research Shares Could See Significant Upside: Analyst ↗
Via Benzinga
News headline image
This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
Via Benzinga
News headline image
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Reports Second Quarter 2025 Financial Results and Provides Business Updates
From GH Research PLC
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
GH Research Announces Global Pivotal Program Plans and Further Development Updates
From GH Research PLC
Via GlobeNewswire
News headline image
GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule
From GH Research PLC
Via GlobeNewswire

Frequently Asked Questions

Is GH Research PLC - Ordinary Shares publicly traded?
Yes, GH Research PLC - Ordinary Shares is publicly traded.
What exchange does GH Research PLC - Ordinary Shares trade on?
GH Research PLC - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for GH Research PLC - Ordinary Shares?
The ticker symbol for GH Research PLC - Ordinary Shares is GHRS on the Nasdaq Stock Market
What is the current price of GH Research PLC - Ordinary Shares?
The current price of GH Research PLC - Ordinary Shares is 20.35
When was GH Research PLC - Ordinary Shares last traded?
The last trade of GH Research PLC - Ordinary Shares was at 06/09/26 04:00 PM ET
What is the market capitalization of GH Research PLC - Ordinary Shares?
The market capitalization of GH Research PLC - Ordinary Shares is 1.06B
How many shares of GH Research PLC - Ordinary Shares are outstanding?
GH Research PLC - Ordinary Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS